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ABSTRACT
During the past 15 years, clinical experience with catheter interventional treatment in patients with Kawasaki disease, includ-
ing balloon angioplasty, stent implantation, rotational ablation, and transluminal coronary revascularization, has been gradual-
ly increasing. Because the coronary artery lesions in Kawasaki disease involve severe calcifications, the indications or catheter 
intervention techniques have not been established for adult patients with Kawasaki disease. Satisfactory acute results for coro-
nary balloon angioplasty have been obtained in patients with a relatively short interval from the onset of disease, especially with-
in 6 years; however, the incidence of restenosis after angioplasty is still high. Rotational ablation may be the most appropriate 
catheter intervention technique for patients with Kawasaki disease. The advantage of rotational ablation is the high success rate, 
even in patients with calcified coronary artery stenosis. Stent implantation requires larger arterial access and is not possible in 
younger children. Care should be paid to the detection of newly-formed aneurysms, as the formation of new aneurysms is asso-
ciated with the use of additional balloon angioplasty using high pressure balloon inflation. Anticoagulation or anti-platelet regi-
mens are essential for long-term management. Coronary intervention in Kawasaki disease requires special techniques and 
knowledge of cardiovascular involvement. The procedure should be managed under the close collaboration between pediat-
ric cardiologists and coronary interventional cardiologists. (Korean Circ J 2011;41:53-57)
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Introduction
Coronary artery involvement is the most important com-
plication of Kawasaki disease (KD), and may cause significant 
ischemic heart disease in children. Acute myocardial infarc-
tion due to thrombus occlusion of a coronary aneurysm is the 
most serious complication in KD. After the introduction of 
high-dose gamma globulin, the incidence of coronary aneu-
rysm formation has declined dramatically. Between 30% and 
50% of such aneurysms regress within the first 2 years; how-
ever, 3-5% of patients have chronic coronary aneurysms which 
may become stenotic and obstructive, thus leading to myo-
cardial infarction. In Japan, >8,000 children have been diagnosed 
with KD annually during the past 10 years. Thus, nearly 400 
children per year develop coronary aneurysms from KD. 
Coronary artery bypass surgery (CABG) has been performed 
for ischemic heart disease caused by KD; however, long-term 
coronary graft patency is not satisfactory, especially in venous 
grafts and patients <8 years of age. Therefore, catheter inter-
vention has its role in KD related to coronary artery disease 
(CAD).
During the past 15 years, clinical experience with the fol-
lowing catheter interventional treatments in patients with KD 
has been gradually increasing:
1) balloon angioplasty;
2)3) stent 
implantation;
4)5) rotational ablation;
6)7) and transluminal coro-
nary revascularization.
8) However, the experiences in KD are 
limited compared to coronary intervention in adults, which 
have provided satisfactory therapeutic results. The coronary 
artery stenosis in patients with KD commonly involves severe 
calcifications, in contrast with adult coronary artery lesions, 
which primarily consist of atherosclerosis.
9)10) Therefore, the 
indication for catheter intervention in adult patients cannot be 
directly applied to patients with KD, most of whom are in 54   Catheter Interventions for Kawasaki Disease
the pediatric population.
11) Indeed, the fundamental thera-
peutic regimen for patients with ischemic heart disease after 
KD is CABG; however, the long-term coronary graft patency 
is not satisfactory, especially in venous grafts or patients <8 
years of age.
12)13) Furthermore, the indications for catheter in-
tervention in patients with KD have not been established, and 
the long-term prognosis after catheter intervention remains 
unclear.
1)11)  
Several types of catheter interventions for the treatment of 
KD have been reported. Although these preliminary reports 
have demonstrated the efficacy of each procedure, the studies 
have been limited and no prospective studies have been per-
formed. Although the use of percutaneous coronary rotation-
al ablation (PTCRA) is still limited, this procedure may be the 
most appropriate catheter intervention for patients with KD. 
The advantage of PTCRA is the high success rate, even in pa-
tients with calcified coronary artery stenoses.
6)7) Care should 
be paid to the detection of newly-formed aneurysms, as the 
formation of new aneurysms is associated with the use of ad-
ditional coronary balloon angioplasty using high pressure 
balloon inflations. The etiology of new aneurysms is likely in-
timal dissection caused by balloon angioplasty rather than ro-
tational ablation. The advantages of this procedure include the 
high vascular patency rates in patients with segmental or rel-
atively long stenoses, and the prevention of new aneurysm for-
mation after percutaneous transluminal coronary balloon an-
gioplasty (PTCA). As with PTCRA, stent implantation requires 
larger arterial access and is not possible in younger children.
Indications for Catheter Intervention
The following patient conditions for catheter intervention 
should be considered.
14)
1) Patients presenting with ischemic symptoms.
2) Patients presenting with no ischemic symptom, but 
shown to have ischemic findings detected by stress testing 
(dipyridamole stress myocardial perfusion scan or dobuta-
mine stress echocardiography).
3) Patients with no ischemic findings detected by stress test-
ing, but >75% of stenotic lesions in the left anterior descend-
ing coronary artery, possibly causing sudden cardiac death by 
obstruction. In such cases, the indication for catheter interven-
tion can be considered. Other therapeutic options, including 
surgical therapy or observation with medications, should also 
be discussed. 
4) Patients with severe left ventricular dysfunction are not 
candidates for catheter intervention, and other options, includ-
ing CABG, should be considered.
The indications by lesion site are as follows:
1) severe stenotic lesions (>75%);
2) localized lesions (contraindication for cases with multi-
ple vessel lesions);
3) no ostial lesions; and
4) no long segmental lesions.
Types of Procedures
Percutaneous transluminal coronary balloon 
angioplasty
PTCA is only useful for stenotic lesions with mild calcifica-
tions or the absence of calcifications within 6 years of disease 
onset.
2) Thus, satisfactory acute results for PTCA have been 
obtained in patients with a relatively short interval between the 
onset of disease and PTCA within 6 years after onset. Howev-
er, the success rate declined to 60% if the interval from the on-
set of disease to the time of PTCA was >10 years. Pathologic ex-
aminations at the time of autopsies have demonstrated mark-
ed intimal thickening secondary to arteritis at the sites of an-
eurysms and stenoses. Multiple calcifications have also been 
detected in the arterial wall.
15) Calcified lesions are observed 
beginning approximately 5 years after onset. The underlying 
obstacle to successful PTCA is reduced compliance of the arte-
rial wall. In the setting of reduced compliance, alternative pro-
cedures, such as rotational ablation, should be attempted.
The incidence of restenosis after PTCA is high.
1) In fact, ap-
proximately, 25% of patients develop restenosis or occlusion. 
The mechanism responsible for restenosis is the same as that 
responsible for failure of adequate balloon dilation. Coronary 
arteries with thick intimal hyperplasia probably recoil easily, 
even if the stenotic vessel has been dilated sufficiently. Stent 
implantation may prevent the occurrence of restenosis in this 
situation.
The development of new coronary aneurysms after PTCA is 
a significant clinical concern. The mechanism responsible for 
this phenomenon is unclear, however intimal and/or medial 
dissection due to high-pressure balloon inflation could play a 
role. In a previous report the maximum balloon pressure in pa-
tients with new aneurysms was >10 atmospheres.
1) Although 
an increase in aneurysm diameter or aneurysmal rupture has 
not been reported, more rigorous trials are necessary to deter-
mine the risk of this complication. Thus, the maximum bal-
loon pressure is recommended to be <8-10 atmosphere at the 
time of PTCA in the pediatric population. Stiff coronary ar-
tery lesions which require higher balloon pressure (>10 atmo-
spheres), rotational ablation or CABG surgery is advisable as 
an alternative procedure. Additionally, when PTCA is defen-
sively performed in young children, a short balloon length 
should be selected.
Stent implantation
Use of stent implantation for KD is limited; however, acute 
results with stent implantation have been excellent. Because 
this procedure relies on balloon dilation, the limitations are 
similar to the limitations for PTCA. The advantages of stent Teiji Akagi   55
implantation include high vascular patency rates in patients 
with segmental or relatively long stenoses, and the prevention 
of new aneurysm formation after PTCA.
8)11) As with rota-
tional ablation, stent implantation requires larger arterial ac-
cess and is not possible in younger children. Stent implantation 
is useful for old children (>13 years) in whom calcifications are 
mild and the stent can be implanted in coronary arteries. Stent 
implantation is also effective in patients in whom the coronary 
blood flow is whirling inside of giant aneurysms because the 
blood vessel diameter can be extended as large as the stent di-
ameter compared to other procedures. The incidence of new 
aneurysms is lower following stent implantation than PTCA 
alone, even if a higher balloon pressure is applied. Maximum 
balloon pressure is recommended not to exceed 14 atmosp-
heres to avoid the formation of neoaneurysms. Stent implan-
tation is ineffective in cases with severe calcifications. Heparin 
should be infused at 800-1,000 U/h. The activated clotting time 
is maintained at 200 seconds or more. Anticoagulation thera-
py with aspirin and clopidogrel is recommended for >2 months 
after the procedure. The long-term results of this procedure in 
patients with KD should be clarified in further studies.
Rotational ablation
PTCRA consists of an abrasive tiny diamond-coated burr 
that removes the lesion with rotation at 200,000 rpm and al-
lows the lumen to dilate. Rotational ablation is also effective in 
cases with severe calcifications. Excellent acute results for PT-
CRA were observed in previous studies.
6)7) Although use of this 
procedure is limited, PTCRA may be the most appropriate cath-
eter intervention for KD. The advantage of PTCRA is the high 
success rate, even in patients with calcified coronary artery ste-
noses. Care should be paid to the detection of new aneurysm 
formation, as the formation of new aneurysms is associated with 
the use of additional PTCA using high-pressure balloon infla-
tion. The etiology of new aneurysms is likely intimal dissection 
caused by balloon angioplasty and not rotational ablation. In-
deed, the findings based on intravascular ultrasound imaging 
support this speculation.
6) Therefore, balloon dilation after PT-
CRA should be avoided. If balloon dilation is required (i.e., for 
persistent residual stenosis) after PTCRA, the balloon pressure 
should be kept low. The limitation of this procedure is the need 
for larger arterial access for the metal burr. For this reason, this 
procedure can only be performed in older patients. Using this 
procedure, the stenotic area can be dilated up to 2.5 mm. Com-
bination of rotational ablation and stent implantation may fa-
cilitate a further enlargement increase the diameter of the cor-
onary artery diameter. As with stent implantation, heparin in-
fusion (800-1,000 U/hour) is critical during the procedure. The 
activated clotting time should be maintained at ≥200 seconds. 
Anti-platelet medication should be continued at least 2 months 
after the procedure.
Percutaneous transluminal coronary 
revascularization 
Acute myocardial infarction most frequently occurs within 
2 years of the onset of KD and is mainly caused by fresh th-
rombi.
9) PTCR and intravenous thrombolysis in this situation 
are thought to be significant in the prevention and therapy of 
myocardial infarction.
8) In particular, frequent and careful ob-
servation with echocardiography is required in cases, such as 
giant coronary aneurysms, which have a high risk for throm-
bus formation. In patients undergoing percutaneous translu-
minal coronary revascularization (PTCR), 25,000 U/kg of 
tissue plasminogen activator (t-PA) is administered. Injection 
of thrombolytic agents directly into the coronary artery and 
intravenous thrombolysis occasionally cause cerebral hemor-
rhage. Repeated doses of the thrombolytic agents should be 
carefully performed in pediatric patients who are predisposed 
to hemorrhage. After PTCR, 100 U/kg/hour of heparin is in-
travenously infused for 12 hours. Thereafter, a small oral dose 
of aspirin or warfarin is administered to prevent thrombus for-
mation. Because t-PA is injected intravenously, an intravenous 
infusion of t-PA (250,000 U/kg) is recommended prior to hos-
pitalization in cases of acute myocardial infarction in pediatric 
patients with KD. However, it is necessary to take careful pre-
cautions against cerebral hemorrhage and arrhythmias 
caused by the systemic administration of t-PA. PTCR or intra-
venous thrombolysis in patients with acute myocardial infarc-
tion is generally effective only within 6 hours after onset. PTCR 
or intravenous thrombolysis may be indicated for fresh throm-
bi in giant coronary aneurysms detected by serial echocardiog-
raphy. The success rate for re-canalization using thrombolytic 
agents is low in cases of asymptomatic myocardial infarctions 
secondary to chronic obstruction with thrombi.
Long-Term Outcome After Intervention
Eighty-eight patients (71 males and 17 females), who devel-
oped coronary stenotic lesions caused by KD were treated with 
catheter interventions in 9 institutions between January 1993 
and June 2002. At the time of the intervention, the subjects 
ranged in age from 11 months to 27 years (mean age, 14±5.5 
years), and the interval between diagnosis of KD and interven-
tion was 137 days to 25 years (mean interval, 11.8±6.3 years). 
Catheter intervention was considered successful when the 
degree of stenosis (diameter) was <50% of the degree of steno-
sis before the procedure 9. Restenosis was present when the 
minimal luminal diameter was reduced by >50%, as confirmed 
by angiography. New coronary aneurysms were defined as aneu-
rysmal coronary enlargement at the same site of intervention 
observed at the time of follow-up angiography. A total of 100 
catheter interventions were performed on the 88 patients. 
The mean follow-up period after catheter intervention was 
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divided into three groups: PTCA (n=21); PTCRA (n=68); 
and stent implantation (n=11). Prior to stent deployment, 6 
and 5 patients underwent PTCA and PTRCA, respectively, at 
the same time. The mean age at onset, intervention, and fol-
low-up period are listed in Table 1. The age at intervention in 
the PTCRA and stent implantation groups was significantly 
older than the PTCA group (p=0.043).
The main long-term results regarding restenosis, neoaneu-
rysms, re-intervention, conversion to CABG, and complications 
are listed in Table 2. The incidence of restenosis was higher in 
the PTCA group (24%) than the PTCRA (17%) and stent inser-
tion groups (9%). The incidence of neoaneurysm formation 
was also higher in the PTCA group (7.4%) than the PTCRA 
group (6.3%); no neoaneurysms were reported in the stent 
bimplantation group. The re-intervention rate was highest in 
the PTCRA group (12.5%) and lowest in the stent implanta-
tion group (0%). The PTCA group had the highest rate of 
conversion to CABG and the highest complication rate. The 
event-free survival curve is demonstrated in Fig. 1, which sh-
owed 1-year event-free ratios of 66.7%, 89.9%, and 90.9% for 
the PTCA, PTCRA, and stent implantation groups, respec-
tively. The 5-year event-free ratios were 66.7%, 69.1%, and 
90.9% for each group. 
In the PTCA group, 5 lesions developed restenoses. We com-
pared these lesions with the other 16 lesions with respect to the 
age at intervention, degree of stenosis, maximal balloon size, 
and maximal pressure. We showed that high-pressure inflation 
tended to cause restenosis (p<0.05), as shown in Table 3. In the 
PTCRA group, 12 lesions had restenoses and the associated 
risk factor was the smaller Burr size, as shown in Table 4.
Role of Intravascular  
Ultrasound Imaging
The histopathologic features of coronary lesions in patients 
with KD change with the duration after onset. In particular, 
calcifications are frequently observed in the area of the coro-
nary stenosis >6 years after onset. The detailed evaluation of 
the severity and extent of calcifications is extremely important 
for the optimal selection of suitable therapeutic procedures. 
Intravascular ultrasound imaging allows detailed structural 
observation of a coronary artery wall. Specifically, the extent 
of calcifications can be precisely evaluated.
15) Intravascular ul-
trasound imaging is desirable to evaluate evaluate the proce-
dure results in detail. 
Institute and Back-Up System
All of the above procedures should be performed at select-
Table 1. Patient profile
 
PTCA 
(n=21)
PTCRA 
(n=68)
Stent
(n=11)
Age at onset (years) 2.9±1.5 2.4±2.2 2.5±2.8
Age at intervention (years) 7.4±5.2 15.4±4.5* 16.1±2.3*
Follow-up (years) 4.2±2.6 3.4±4.2 4.0±2.5
*Means p<0.05 compared with the PTCA group. PTCA: percuta-
neous transluminal coronary balloon angioplasty, PTCRA: percu-
taneous coronary rotational ablation
Table 2. Main results of interventions
 
PTCA
(n=21)
PTCRA
(n=68)
Stent
(n=11)
Restenosis (%) 240. 170. 9
Neoaneurysm (%) 07.4 06.3 0
Re-intervention (%) 03.7 12.5 0
CABG (%) 18.5 0. 9
Complications (%) 14.8 10.4 9
PTCA: percutaneous transluminal coronary balloon angioplasty, 
PTCRA: percutaneous coronary rotational ablation, CABG: coro-
nary artery bypass surgery
Table 3. Risk factors of restenosis after PTCA
Restenosis (+)
(n=5)
Restenosis (-)
(n=16)
p
Age at intevention (years) 9.1±4.3 9.7±6.9 NS
Degree of stenosis (%) 94±9 89±12 NS
Maximum balloon size (mm) 2.9±0.5 3.1±0.7 NS
Maximum pressure (atm) 14.3±6.8 8.4±2.0 0.03
PTCA: percutaneous transluminal coronary balloon angioplasty
Table 4. Risk factors of restenosis after PTCRA
 
Restenosis (+) 
(n=12)
Restenosis (-) 
(n=56)
p
Age at intervention 
  (years)
13.3±1.9 14.8±3.4 NS
Degree of stenosis
  (%)
89±6 88±9 NS
Burr size (mm) 02.05±0.18 02.22±0.27 0.043
PTCRA: percutaneous coronary rotational ablation
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Fig. 1. Event free survival of various interventions.Teiji Akagi   57
ed institutions with experience in coronary interventional pro-
cedures by highly experienced interventional cardiologists. Co-
operation between pediatric and adult cardiologists is essen-
tial for optimal decision-making in this setting. Patients should 
be referred by a cardiologist who has fully knowledge of not 
only the catheter intervention, but also the clinical features and 
the natural course of the disease.
16) The indications for cathe-
ter intervention and appropriate anti-thrombus regimen after 
interventional catheterization require further clarification in 
the setting of KD based on the natural history of the coronary 
artery lesion, especially vascular endothelial function.
17-19)
Recommendations
The current study did not establish guidelines for the use 
of catheter intervention in patients with KD. However, based 
on our results, we propose the following recommendations.
20-23) 
PTCA is effective in many situations, particularly in patients 
without severe calcifications or in patients with a relatively short 
interval (<6 years) between the onset of disease and the inter-
vention. Based on recent improvements in balloon catheters, 
this procedure may be used, even in small children. Therefore, 
PTCA may become a first-line procedure in younger children 
with significant coronary artery stenosis. Stent implantation is 
preferable to PTCA because it may prevent new aneurysm for-
mation and restenosis. In patients older than adolescents, stent 
implantation should be considered instead of PTCA alone. If 
patients have severe calcified coronary stenoses, PTCRA may 
be the only effective treatment. Intravascular ultrasound imag-
ing provides valuable information for the selection of the ap-
propriate interventional procedures and early detection of vas-
cular complications. 
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